AskMed

Best AI for Neurology: Cited Answers on Stroke, Seizures and Headache

Our pick first, then the other tools neurologists, stroke and emergency teams, neuro nurses, pharmacists and students weigh for questions on TIA, acute stroke, headache, first seizures and the Glasgow Coma Scale.

Updated

Our pick

AskMed

AskMed is our pick for neurology questions. It answers from AHA/ASA, AAN and NICE guidance, major journals and drug labels, links every claim to its source, and works for doctors, nurses, pharmacists, students and researchers worldwide.

Answers fromJournals, clinical guidelines, drug labels and clinical references
Sources for the brainStroke and other AHA journals, Neurology, NICE, NEJM, The Lancet, JAMA, The BMJ, PubMed, PubMed Central and the Cochrane Library
CitationsA link after every claim; 8 sources per answer by default, 3–12 if you change it
GuidelinesThe year of each recommendation, and what changed when guidance was updated
No source foundSays so, never answers from memory
ReportsText from an attached PDF or photo is read; CT, MRI and EEG tracings are not interpreted
DosesNever, including thrombolysis and antiseizure medicines
Built forDoctors, nurses, pharmacists, students, researchers
WhereWorldwide, no US license or NPI needed
DevicesiPhone, iPad, Android, web

Which AI tools answer neurology questions?

This guide compares the AI tools that neurologists, stroke and emergency teams, neuro nurses, pharmacists and students weigh for questions about the brain and nerves, and each one does a different job. AskMed is an AI medical reference that answers questions on TIA, acute stroke, headache, seizures and coma scales from journals, guidelines and drug labels, with a link after every claim, for anyone in medicine in any country. OpenEvidence is a clinical AI search engine for verified healthcare professionals; its App Store listing says an NPI is required. UpToDate Expert AI is the AI companion to the UpToDate clinical reference and needs an UpToDate subscription with Expert AI enabled. ChatGPT is OpenAI's general chatbot. AI scribes, billing software and tools that read EEG tracings or brain scans are different categories and are left out here. The table shows what each tool is, where its answers come from and who can use it.

ToolTypeAnswers fromWho can use it
AskMedAI medical referenceAHA/ASA guidelines in Stroke, the journal Neurology, NICE, major journals, PubMed and drug labels, with a link after every claimDoctors, nurses, pharmacists, students and researchers, worldwide; no NPI
OpenEvidenceClinical AI searchPeer-reviewed literature; partners include NEJM and JAMAVerified healthcare professionals; NPI required, per its App Store listing; not available in the UK, EU or EEA, per its Terms
UpToDate Expert AIAI companion to UpToDateUpToDate contentHolders of an UpToDate subscription with Expert AI enabled
ChatGPTGeneral AI chatbotNot limited to medical sourcesAnyone

OpenEvidence

OpenEvidence describes itself as a clinical decision support platform and medical search engine for healthcare professionals. Its US App Store listing names NEJM, JAMA and its 11 specialty journals, NCCN, Nature, the Cochrane Library and Wiley as official AI partners, and lists content agreements with medical societies. The listing marks an NPI as required, says users must verify their healthcare professional status, and says the app contains advertising. OpenEvidence's Terms of Use say the service is not available in the European Union, the United Kingdom or the European Economic Area, so stroke and neurology teams there need another tool. AskMed vs OpenEvidence compares the two in detail.

UpToDate Expert AI

UpToDate Expert AI is an AI-powered companion to the UpToDate clinical reference. Its App Store listing says it gives evidence-based responses grounded in UpToDate content, and that access requires an UpToDate subscription with Expert AI enabled, through an enterprise account or a personal subscription. It suits clinicians whose hospital already uses UpToDate. AskMed vs UpToDate Expert AI compares the two side by side.

ChatGPT

ChatGPT is OpenAI's general AI chatbot, on the web, iPhone and Android. It helps to talk through neuroanatomy or draft a seizure safety leaflet, but it is not limited to medical sources, so check any clinical claim against the guideline first. OpenAI also runs ChatGPT for Clinicians, which its help center opens to verified US clinicians with an NPI and a license check. Is ChatGPT accurate for medical questions? covers what studies found.

Guideline resources without AI chat

Many neurology teams keep the guideline itself open next to their AI tool. The American Heart Association and American Stroke Association publish their stroke guidelines in the journal Stroke, and the American Academy of Neurology lists its guidelines at its guidelines page on aan.com. In the UK, NICE publishes NG128 on stroke and TIA in over 16s (May 2019, last updated April 2022), CG150 on headaches in over 12s (September 2012, last updated June 2025) and NG217 on the epilepsies (April 2022, last updated August 2026). These are for reading the guideline itself, which is also where an AI answer should lead you.

How does AskMed answer a neurology question?

AskMed answers a neurology question in four steps, and you can check each one. First, AskMed rewrites the question as a medical search query, and for management questions it adds "latest guideline update" so the newest guidance is found. Second, AskMed searches a fixed list of medical sites, never the open web or forums; for the brain, that list includes ahajournals.org, where Stroke publishes AHA/ASA guidelines, neurology.org, home of the AAN's journal Neurology, and NICE, NEJM, The Lancet, JAMA, The BMJ, PubMed, PubMed Central and the Cochrane Library, plus FDA and DailyMed drug labels. Third, AskMed ranks what it found: guidelines and health agencies first, then systematic reviews and meta-analyses, then reviews and references, then large trials, preferring work from the last 10 years. Fourth, an AI language model writes the answer with a link after every claim, gives the year of each guideline recommendation and says so when sources disagree. If no usable source turns up, AskMed says that instead of answering from memory.

The AAN's own website, aan.com, is not on that list, so an AAN guideline reaches AskMed when it is published in Neurology or indexed on PubMed, as the 2015 guideline on a first unprovoked seizure is. For evidence questions such as "Does tenecteplase do as well as alteplase in acute ischemic stroke?", Research Mode reads the most relevant source in full before it writes the answer. How AskMed answers lists every source.

Can AI help assess a TIA and its stroke risk?

AI can help assess a transient ischaemic attack by stating the current definition, listing the work-up the guidelines ask for and explaining what a risk score does and does not tell you, with a source for each step, but it cannot tell a TIA from a mimic at the bedside. The 2009 AHA/ASA scientific statement by Easton and colleagues in Stroke defines TIA as a transient episode of neurological dysfunction caused by focal brain, spinal cord or retinal ischaemia, without acute infarction. It advises neuroimaging within 24 hours of symptom onset, preferably MRI with diffusion sequences, noninvasive imaging of the neck vessels, and an ECG as soon as possible. In the UK, NICE NG128 says to refer everyone with a suspected TIA immediately, to be seen by a specialist within 24 hours of symptom onset (recommendation 1.1.5), and not to use scoring systems such as ABCD2 to set that urgency (1.1.6). AskMed searches both sources directly.

Can AI check thrombolysis eligibility in acute stroke?

AI can lay out thrombolysis eligibility criteria as the guidelines state them, which helps on a revision night or before a stroke call, but the decision belongs to the stroke team with the patient and the scan in front of them. The 2026 AHA/ASA guideline for the early management of acute ischemic stroke by Prabhakaran and colleagues, published online in Stroke in January 2026, replaces the 2018 guideline and its 2019 update, with new evidence on thrombolytic choice and eligibility and a changed approach to contraindications. It recommends treatment as quickly as possible for eligible adults within 4.5 hours of symptom onset, with either alteplase or tenecteplase, and says extended-window thrombolysis may be reasonable when imaging selects the patient. NICE NG128 covers thrombolysis within 4.5 hours of symptom onset once intracranial haemorrhage has been excluded, and points to its technology appraisals of tenecteplase (TA990, 2024) and alteplase (TA264, 2012). AskMed names the agents and never gives their doses.

IV thrombolysis Within 4.5 h 4.5–9 h, imaging-selected Thrombectomy (large vessel occlusion) Within 6 h 6–24 h, imaging-selected Hours from symptom onset or last known well (not to scale)
Reperfusion windows in the 2026 AHA/ASA guideline and NICE NG128. Extended windows depend on brain imaging, such as an MRI diffusion–FLAIR mismatch or perfusion imaging showing tissue that can be saved.

Can AI sort headache red flags from a primary headache?

AI can sort headache red flags by checking the history you give it against a published list and saying which features call for investigation or referral, with a citation for each, but it cannot examine the fundi or the neck. NICE CG150, Headaches in over 12s, tells clinicians to evaluate people whose headache comes with any of a set of features and to consider further investigation or referral (recommendation 1.1.1). The list includes worsening headache with fever, sudden-onset headache reaching maximum intensity within 5 minutes, a new neurological deficit, new cognitive dysfunction, a change in personality, impaired consciousness, head trauma typically within the past 3 months, headache triggered by cough, Valsalva, sneeze or exercise, orthostatic headache, symptoms of giant cell arteritis or acute narrow-angle glaucoma, and a substantial change in the headache's character. The SNNOOP10 list, published in Neurology in 2019 by Do and colleagues, groups 15 red and orange flags for secondary headache.

Can AI guide the work-up after a first seizure?

AI can guide the work-up after a first seizure by listing the history, tests and referral the guidelines ask for and the recurrence figures to share with the patient, with a source for each, but it cannot tell an epileptic seizure from syncope without the account of what happened. NICE NG217 says to refer children, young people and adults urgently after a first suspected seizure, for an assessment within 2 weeks by a clinician with expertise in first seizures (recommendation 1.1.1). It asks for a detailed history with eyewitness accounts or video where possible, a 12-lead ECG to look for cardiac causes, awareness that hypoglycaemia and other metabolic disturbance can cause seizures, and brain imaging if a structural cause is suspected. It says not to use EEG to exclude epilepsy, and to do any EEG after a first seizure as soon as possible, ideally within 72 hours. MRI is offered once epilepsy is diagnosed, except in idiopathic generalised epilepsy and self-limited epilepsy with centrotemporal spikes.

Can AI score the Glasgow Coma Scale?

AI can explain the Glasgow Coma Scale and check a score you have worked out, but a calculator is quicker for the sum and only the person at the bedside can rate the responses. Teasdale and Jennett described the scale in The Lancet in 1974. Each of the three responses is rated by the best one seen: eye opening from 1 to 4, verbal response from 1 to 5 and motor response from 1 to 6, giving a total from 3 to 15, written as E-V-M notation such as E2V4M6. When a response cannot be tested, for example because the eyes are closed by swelling or the patient is intubated, it is recorded as not testable (NT) and no total is reported. Teasdale and colleagues' 2014 review in The Lancet Neurology advises describing a patient by the three responses rather than the total alone. AskMed can cite both papers and the structured approach.

What should residents, nurses, pharmacists and students look for in a neurology AI?

Neurology residents, stroke and neuro nurses, pharmacists and students need an AI tool whose answers can be checked in seconds and that names the guideline edition it quotes. Four checks matter. First, citations: each claim should link to the guideline, trial or drug label behind it, not to a reading list at the end. Second, the edition: the AHA/ASA replaced its 2018 acute ischemic stroke guideline and 2019 update in 2026, and NICE last updated NG217 on the epilepsies in August 2026, so an answer should give the year. Third, doses: AskMed explains how thrombolysis and antiseizure medicines are chosen and monitored without giving amounts. Fourth, access: OpenEvidence's App Store listing says an NPI is required and its Terms exclude the UK, EU and EEA, and UpToDate Expert AI needs an UpToDate subscription with Expert AI enabled. AskMed needs no NPI or license, works in any country and carries no pharma advertising.

What are the limits of AI for neurology?

The main limit of AI for neurology is that neurology runs on the examination and the scan, and an AI tool sees neither, so an answer is only as good as the history it was given and the sources it found. AskMed searches a fixed list of medical sites, so guidance published elsewhere may reach AskMed only as a PubMed abstract or an article in Neurology, and every AskMed answer is written by an AI language model that can misread a source; no person reviews it first. Open the citation behind any sentence you act on and check that it covers the same patients, since evidence on adults does not answer a question about a child's first seizure. AskMed reads text, not CT or MRI images and not EEG tracings, and it gives no doses. AskMed is for education and reference by healthcare professionals and students, not for emergencies or for patients' self-diagnosis; a suspected stroke needs the local stroke pathway now.

Questions

What is the best AI for neurology?

AskMed is the best AI for neurology questions when you need an answer you can check. AskMed searches a fixed list of medical sources, including the AHA journal Stroke, the AAN journal Neurology, NICE, NEJM, The Lancet, JAMA, The BMJ, PubMed and the Cochrane Library, then writes an answer with a link after every claim and the year of each guideline recommendation. If it finds no usable source, it says so instead of answering from memory, and it never gives doses. AskMed is built for doctors, nurses, pharmacists, students and researchers, works worldwide without an NPI, and runs on iPhone, iPad, Android and the web. OpenEvidence serves verified healthcare professionals with an NPI, and UpToDate Expert AI answers from UpToDate content.

Does AskMed use the 2026 AHA/ASA stroke guideline?

AskMed searches ahajournals.org, where Stroke publishes AHA/ASA guidelines, and gives the year of each recommendation. When we checked in November 2026, the current acute ischemic stroke guideline was the 2026 AHA/ASA guideline, which replaced the 2018 guideline and its 2019 update.

Can AskMed work out an ABCD2 or GCS score?

AskMed explains what each score means and cites the paper behind it. For the sum itself, the ABCD2 score calculator and the Glasgow Coma Scale calculator on getaskmed.com give the score and its band in a few taps.

Does AskMed give doses for thrombolysis or antiseizure medicines?

No. AskMed explains which medicines the guidelines name, why and what to monitor, but never gives doses, amounts or schedules. Those come from the current label, the local protocol and the treating clinician.

Can AskMed read a CT, MRI or EEG?

No. AskMed reads attached images for their printed text only, so it cannot interpret a scan or an EEG tracing. Paste the radiology or EEG report text, and AskMed gives a cited explanation and next steps.

Is AskMed only for neurologists?

No. AskMed is built for doctors in any specialty, nurses, pharmacists, medical students and researchers, on iPhone, iPad, Android and the web, in English, French, Spanish, Portuguese, Italian, Japanese and Arabic.

Cited medical answers
you can trust.

AskMed on iPhone, iPad, Android and the web.